Total amount raised
$553.1 Million
Latest funding date
2022-02-09
Location
Twist Bioscience has developed a proprietary semiconductor-based synthetic DNA manufacturing process, offering customizable gene synthesis, variant libraries, and next-generation sequencing solutions. The company's high-throughput silicon platform allows for significant time and cost savings in DNA synthesis.
Keep reading to explore the intricacies of Twist Bioscience's fundraising journey and the investors backing this innovative platform.
What Is Twist Bioscience?
Twist Bioscience is a biotechnology company specializing in DNA synthesis and synthetic biology. The company offers a range of products, including genes, oligo pools, NGS target enrichment solutions, variant libraries, synthetic controls, and antibody discovery services.
Headquartered in South San Francisco, CA, Twist Bioscience uses a proprietary semiconductor-based synthetic DNA manufacturing process to provide high-quality, customizable DNA tools for various scientific research applications. The company is recognized for its innovation and has received several accolades, including being listed among the Most Innovative Biotech Companies of 2021.
How Much Funding Has Twist Bioscience Raised?
- Series A
- Amount Raised: USD 9,110,714
- Date: February 2014
- Lead Investors: ARCH Venture Partners, Asset Management Ventures (AMV)
- Series B
- Amount Raised: USD 26,000,000
- Date: May 2014
- Lead Investors: Tao Venture Partners
- Debt Financing
- Amount Raised: USD 10,000,000
- Date: September 2014
- Series C
- Amount Raised: USD 37,000,000
- Date: June 2015
- Lead Investors: Illumina
- Series D
- Amount Raised: USD 61,000,000
- Date: January 2016
- Series Unknown
- Amount Raised: USD 33,000,000
- Date: March 2017
- Series Unknown
- Amount Raised: USD 27,000,000
- Date: June 2017
- Lead Investors: Biomatics Capital Partners
- Series Unknown
- Amount Raised: USD 50,000,000
- Date: April 2018
- Post-IPO Equity
- Amount Raised: USD 50,000,000
- Date: January 2020
- Post-IPO Equity
- Amount Raised: USD 250,000,000
- Date: February 2022
- Lead Investors: Capital World Investors
Twist Bioscience has raised a total of USD 553,110,714 across various funding rounds.
Key Investors
- Capital World Investors
- Details: Capital World Investors is a division of Capital Group, one of the world's largest investment management organizations. They manage equity assets for institutional and individual investors globally.
- Investment Focus Areas: Technology, healthcare, financial services
- Notable Investments: Amazon, Microsoft, Alphabet
- Biomatics Capital Partners
- Details: Biomatics Capital Partners is a venture capital firm that invests in transformative healthcare and life sciences companies. They focus on early-stage investments that have the potential to significantly impact human health.
- Investment Focus Areas: Biotechnology, digital health, medical devices
- Notable Investments: GRAIL, Recursion Pharmaceuticals, TwinStrand Biosciences
- Illumina
- Details: Illumina is a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Their innovative solutions are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.
- Investment Focus Areas: Genomics, biotechnology, healthcare
- Notable Investments: Adaptive Biotechnologies, Twist Bioscience, Grail
- Tao Venture Partners
- Details: Tao Venture Partners is a venture capital firm that invests in early-stage technology companies. They focus on companies that have the potential to disrupt existing markets and create new ones.
- Investment Focus Areas: Technology, healthcare, clean energy
- Notable Investments: Tesla, SpaceX, SolarCity
- ARCH Venture Partners
- Details: ARCH Venture Partners is a venture capital firm that invests in the development of seed and early-stage advanced technology companies. They have a strong focus on life sciences, physical sciences, and information technology.
- Investment Focus Areas: Biotechnology, pharmaceuticals, information technology
- Notable Investments: Illumina, Alnylam Pharmaceuticals, Twist Bioscience
Use Clay to Get Funding Data
Sales professionals, leverage Clay’s platform to access comprehensive fundraising data on companies like Twist Bioscience and gather other critical business insights.
Sign up for free to start transforming your sales strategy today.
